Ocular Therapeutix (OCUL) News Today → Watch this FREE trading tutorial while it’s still available (From InvestorPlace) (Ad) Free OCUL Stock Alerts $6.17 +0.30 (+5.11%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOcular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024globenewswire.com - May 3 at 7:30 AMOcular Therapeutix (NASDAQ:OCUL) Trading 10% Higher marketbeat.com - May 2 at 2:46 PMOcular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024globenewswire.com - May 1 at 7:30 AMOcular Therapeutix (NASDAQ:OCUL) Trading 10.7% Higher americanbankingnews.com - April 28 at 5:02 AMOcular Therapeutix (NASDAQ:OCUL) Shares Up 10.7%marketbeat.com - April 26 at 8:32 PMOcular Therapeutix (NASDAQ:OCUL) Shares Down 5% marketbeat.com - April 24 at 6:15 PM2 Small-Cap Growth Stocks With Room To Runfool.com - April 24 at 8:30 AMOptimistic Buy Rating for Ocular Therapeutix Amid Early-Stage NPDR Study and Wet AMD Potentialmarkets.businessinsider.com - April 22 at 10:52 AMBaird sees weakness in Ocular shares as "overdone"msn.com - April 19 at 10:41 PMAnalysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Ocular Therapeutix (OCUL)markets.businessinsider.com - April 19 at 12:40 PMOcular Therapeutix (NASDAQ:OCUL) Sees Strong Trading Volumemarketbeat.com - April 19 at 11:58 AMOcular Therapeutix (NASDAQ:OCUL) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - April 19 at 8:19 AMOcular Therapeutix Shares Dive on Axpaxli Trial Resultsmarketwatch.com - April 18 at 5:40 PMOcular Therapeutix (NASDAQ:OCUL) Stock Price Down 9.2%marketbeat.com - April 18 at 12:59 PMOcular Therapeutix Reports Positive Phase 1 Data For Axpaxli In NPDRmarkets.businessinsider.com - April 18 at 12:37 PMOcular marks early-stage trial win for diabetic retinopathy candidateseekingalpha.com - April 18 at 7:37 AMOcular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathyglobenewswire.com - April 18 at 7:00 AMAge-related Vision Dysfunction Market Size in the 7MM is anticipated to increase by 2032, estimates DelveInsighttheglobeandmail.com - April 17 at 9:08 PMOcular Therapeutix appoints new CEO amid leadership shiftuk.investing.com - April 17 at 4:02 PMOcular Therapeutix (NASDAQ:OCUL) Shares Gap Up to $7.79marketbeat.com - April 17 at 11:37 AMAnalysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Ocular Therapeutix (OCUL) and Elevance Health (ELV)markets.businessinsider.com - April 17 at 10:57 AMThe Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Expertsmarkets.businessinsider.com - April 16 at 6:27 PMJMP Securities Reaffirms Market Outperform Rating for Ocular Therapeutix (NASDAQ:OCUL)marketbeat.com - April 16 at 11:21 AMOcular Therapeutix(TM) Strengthens Clinical Team with Appointment of Key Retinal Leadersstockhouse.com - April 16 at 7:53 AMOcular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leadersfinance.yahoo.com - April 16 at 7:53 AMShort Interest in Ocular Therapeutix, Inc. (NASDAQ:OCUL) Increases By 28.9%marketbeat.com - April 15 at 5:09 PMBiotech on a Budget: 7 Stocks Under $10 With Huge Potentialinvestorplace.com - April 15 at 12:54 PMOcular Therapeutix (NASDAQ:OCUL) Shares Gap Down to $7.99marketbeat.com - April 15 at 12:53 PMOcular Therapeutix CEO Mattessich Steps Down, Executive Chairman Fills Rolemarketwatch.com - April 15 at 10:54 AMOcular Therapeutix CEO Mattessich To Step Down, Dugel To Succeedmarkets.businessinsider.com - April 15 at 10:54 AMOcular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEOglobenewswire.com - April 15 at 7:00 AMRemedies Recommended For Ocular Rosaceamsn.com - April 13 at 3:24 PMOcular Therapeutix (NASDAQ:OCUL) Shares Up 3.9%marketbeat.com - April 11 at 1:47 PMOcular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometricsglobenewswire.com - April 9 at 7:30 AMOcular Therapeutix (NASDAQ:OCUL) Shares Gap Up to $8.44marketbeat.com - April 8 at 11:36 AMBuy Rating Affirmed: Paxtrava’s Promising Efficacy and Safety Profile in Glaucoma Treatmentmarkets.businessinsider.com - April 8 at 2:39 AMOcular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meetingglobenewswire.com - April 6 at 10:00 AMOcular Therapeutix (NASDAQ:OCUL) Stock Rating Lowered by StockNews.commarketbeat.com - April 5 at 11:10 PMOcular Therapeutix (NASDAQ:OCUL) Trading Up 5.3%marketbeat.com - April 4 at 2:03 PMOcular Therapeutix (NASDAQ:OCUL) Trading Down 4%marketbeat.com - April 1 at 2:58 PMMillion-Dollar Bets: 3 Under-$15 Stocks With Massive Potentialinvestorplace.com - April 1 at 10:09 AMDeltec Asset Management LLC Grows Stake in Ocular Therapeutix, Inc. (NASDAQ:OCUL)marketbeat.com - March 31 at 8:00 PMOcular Therapeutix™ To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery)globenewswire.com - March 26 at 7:30 AMLegato Capital Management LLC Invests $667,000 in Ocular Therapeutix, Inc. (NASDAQ:OCUL)marketbeat.com - March 25 at 6:10 AMQ4 2023 Clearside Biomedical Inc Earnings Callfinance.yahoo.com - March 21 at 2:00 AMOcular Therapeutics' Impressive Surge: A Strategic Insightseekingalpha.com - March 19 at 4:04 PMOcular Therapeutix (NASDAQ:OCUL) Stock Rating Upgraded by StockNews.commarketbeat.com - March 18 at 2:27 AMHC Wainwright Brokers Raise Earnings Estimates for Ocular Therapeutix, Inc. (NASDAQ:OCUL)marketbeat.com - March 18 at 1:28 AMOCUL Apr 2024 12.500 putfinance.yahoo.com - March 17 at 8:32 AMOcular Therapeutix (NASDAQ:OCUL) Shares Up 4.8%marketbeat.com - March 15 at 12:37 PM Get Ocular Therapeutix News Delivered to You Automatically Sign up to receive the latest news and ratings for OCUL and its competitors with MarketBeat's FREE daily newsletter. Email Address Watch this FREE trading tutorial while it’s still available (Ad)On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges. Click here for details. OCUL Media Mentions By Week OCUL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCUL News Sentiment▼0.210.43▲Average Medical News Sentiment OCUL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCUL Articles This Week▼43▲OCUL Articles Average Week Get Ocular Therapeutix News Delivered to You Automatically Sign up to receive the latest news and ratings for OCUL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AUPH News Today ARCT News Today PLRX News Today LBPH News Today ALXO News Today SAGE News Today PRTC News Today NRIX News Today DNTH News Today BCYC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OCUL) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingJeff Bezos Just Humiliated Elon MuskInvestorPlaceForget Nvidia. This is the future of AIPorter & CompanyThe asset beating inflation by 4xColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocular Therapeutix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
